Table 2.

Overall survival of hepatocellular carcinoma patients after liver transplantation based on preoperative variables

Parameters	n	Survival, %			P-value
		1 year	3 years	5 years
Gender
Male	155	82.6	74.2	61.9	0.3072
Female	31	90.0	83.3	64.0
Age, years
≤40	19	83.3	83.3	59.8	0.6749
41–50	56	91.1	78.6	76.8
51–60	79	73.8	68.8	66.1
>60	32	96.9	84.4	59.5
α-fetoprotein, KIU/l
<50	119	86.6	81.5	71.2	0.2072
50–200	33	84.9	72.7	65.2
>200	30	73.3	56.7	53.1
Number of tumours
>3	11	72.7	72.7	32.7	0.0412
≤3	142	83.8	73.9	67.6
Tumour size
>5 cm	11	54.6	36.4	18.2	0.0002
≤5 cm	131	87.0	79.4	72.4
Milan Criteria
Within	112	88.4	79.5	74.3	0.0164
Outside	31	71.0	64.5	43.0
UCSF Criteria (radiological)
Within	126	87.3	78.6	73.1	0.0009
Outside	17	64.7	58.8	27.5
Pre-transplant treatment of HCC
Yes	56	83.2	65.2	60.9	0.9736
No	121	87.5	78.6	67.9
Unknown	9	–	–	–
Era of transplant
1985–1990	16	62.5	50.0	37.4	0.0500
1991–1995	13	92.3	92.3	76.9
1996–2003	157	85.4	77.1	69.3
Diagnosis of HCC
Pre-LTx	146	82.2	72.6	64.9	0.1336
Incidental	38	89.5	86.8	74.3

UCSF, University of California San Francisco; HCC, hepatocellular carcinoma; LTx, liver transplantation